Clinical Trial: PRISM Neurofeedback Training for MDD Anhedonic Patients
Study Status: Completed
Recruit Status: RECRUITING
Condition: Depression
Study Type: INTERVENTIONAL
Official Title: Personalizing Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia Using Clinical Biomarkers for MDD Subtypes
Brief Summary:
The goal of this interventional double-blind study is to demonstrate the safety and efficacy of PRISM neurofeedback training within an MDD Anhedonia sample.The main questions it aims to answer are:what clinical profile / symptoms-based biomarkers scores can be used by clinics to administer PRISM therapy in conjunction with standard care of therapy?What are the initial guidelines for integrating PRISM neurofeedback training for MDD therapy with MDD Anhedonia?Participants will be randomly assigned to one of two…
Read more